A groundbreaking study reveals that a daily low dose of aspirin can significantly reduce the risk of colorectal cancer ...

The emergence of drug resistance remains one of the greatest challenges in effective cancer therapy. Despite advances in ...

A new study has revealed that a common over-the-counter medication, aspirin, can cut the risk of colorectal cancer recurrence ...

Liver fibrosis, a pathological scarring process resulting from chronic liver injury, represents a significant global health ...

There have been few studies on the specific signaling pathways involved in the transformation of epithelial cells by oncogenic protein tyrosine kinases. Here we investigate the requirement of MAP ...

A clinical trial called ALASCCA, which has been published in The New England Journal of Medicine, shows that patients with colorectal cancer, who have specific mutations in the PI3K signalling pathway ...

Low-dose aspirin significantly reduced colorectal cancer recurrence in genetically defined patients. A team of researchers led by Karolinska Institutet and Karolinska University Hospital has demonstra ...

New evidence reveals that a daily aspirin regimen can dramatically lower the likelihood of colorectal cancer returning in patients identified as high ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.